Clinical Trial
doi: 10.1007/BF01650505.
Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients
Affiliations
- PMID: 3286513
- DOI: 10.1007/BF01650505
Item in Clipboard
Clinical Trial
Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients
Infection.
1988.
Abstract
A single dose therapy of 500 mg ciprofloxacin was sufficient to cure 15 of 18 chancroid patients within six days and the remaining three within 7, 11 and 20 days respectively. The drug was well tolerated, and no serious side effects were observed. The MICs of ciprofloxacin for the isolated Haemophilus ducreyi strains ranged from 0.0015 to 0.02 mg/l (mean 0.01 mg/l). It may therefore be concluded from our study that the oral administration of ciprofloxacin to chancroid patients with or without buboes is highly effective and free from side effects.
Similar articles
-
Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.Antimicrob Agents Chemother. 1988 May;32(5):723-5. doi: 10.1128/AAC.32.5.723. Antimicrob Agents Chemother. 1988. PMID: 3293526 Free PMC article. Clinical Trial.
-
Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.Am J Med. 1987 Apr 27;82(4A):317-20. Am J Med. 1987. PMID: 3555055 Clinical Trial.
-
Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.Clin Infect Dis. 1995 Apr;20(4):924-30. doi: 10.1093/clinids/20.4.924. Clin Infect Dis. 1995. PMID: 7795096 Clinical Trial.
-
Treatment of chancroid, 1989.Rev Infect Dis. 1990 Jul-Aug;12 Suppl 6:S580-9. doi: 10.1093/clinids/12.supplement_6.s580. Rev Infect Dis. 1990. PMID: 2201074 Review.
-
Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen?Expert Rev Anti Infect Ther. 2014 Jun;12(6):687-96. doi: 10.1586/14787210.2014.892414. Epub 2014 Mar 6. Expert Rev Anti Infect Ther. 2014. PMID: 24597521 Review.
Cited by
-
Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.Antimicrob Agents Chemother. 1989 Oct;33(10):1662-7. doi: 10.1128/AAC.33.10.1662. Antimicrob Agents Chemother. 1989. PMID: 2686546 Free PMC article. Review. No abstract available.
-
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010. Drugs. 1996. PMID: 8736621 Review.
-
Quinolone antibacterial agents for the treatment of genitourinary tract infections.Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1111-6. doi: 10.1007/BF01975178. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2695332 Review.